River Vision Development Secures $17,000,000 Series A Round

  • Feed Type
  • Date
    12/13/2012
  • Company Name
    River Vision Development
  • Mailing Address
    One Rockefeller Plaza New York, NY 10020
  • Company Description
    River Vision Development Corp. was founded by Narrow River Management, LP (Narrow River) for the sole purpose of developing RV001 for GO and other potential indications. The Company is managed under contract with Narrow River, which founds and provides leadership expertise for special purpose drug development companies.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    River Vision Development Corp. today announced the completion of a Series A financing, raising $17 million for the development of a novel protein therapy, RV 001, for the treatment of Graves’ Orbitopathy (GO).
  • M&A Terms
  • Venture Investor
    SR One
  • Venture Investor
    Lundbeckfond Ventures
  • Venture Investor
    Narrow River Management

By posting a comment, you agree to our terms and conditions.